Werewolf Therapeutics, Inc. (HOWL)
NMS – Real vaqt narxi. Valyuta: USD
0.63
-0.03 (-4.31%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.66
+0.03 (4.89%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
0.63
-0.03 (-4.31%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.66
+0.03 (4.89%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
Werewolf Therapeutics, Inc., biotexnologiya kompaniyasi, saraton va boshqa immunitet vositachiligidagi kasalliklarni davolash uchun organizmning immunitet tizimini rag'batlantirish uchun mo'ljallangan terapevtik vositalarni ishlab chiqish bilan shug'ullanadi. Kompaniya o'zining eksklyuziv PREDATOR platformasi orqali an'anaviy yallig'lanishga qarshi immunitet terapiyalarining cheklovlarini bartaraf etish uchun adaptiv va tug'ma immunitetni rag'batlantiruvchi shartli faollashtirilgan molekulalarni ishlab chiqadi. Uning asosiy mahsulot nomzodlari orasida WTX-124, rivojlangan yoki metastatik qattiq o'smalarni davolash uchun shartli faollashtirilgan interleykin-2 INDUKINE molekulasi; va WTX-330, rivojlangan yoki metastatik qattiq o'smalar va limfomani davolash uchun shartli faollashtirilgan interleykin-12 INDUKINE molekulasi mavjud. Kompaniya shuningdek, saratonni davolash uchun shartli faollashtirilgan interferon alfa INDUKINE molekulasi JZP898; yallig'lanishli ichak kasalliklari va potentsial boshqa yallig'lanish kasalliklarini davolash uchun shartli faollashtirilgan IL-10 INDUKINE molekulasi WTX-921; hamda saratonni davolash uchun faollashtirilgan Interleykin-21 (IL-21) WTX-712 va faollashtirilgan IL-18 (IL-18) INDUKINE molekulasi WTX-518ni ishlab chiqmoqda. Molding, u prostata saratonini davolash uchun STEAP 1ni nishonga olgan shartli faollashtirilgan INDUCER T hujayra bog'lovchi molekulasi WTX-1011; hamda tuxumdon va buyrak saratonini davolash uchun CDH6ni nishonga olgan WTX-2022ni ishlab chiqadi. Werewolf Therapeutics, Inc. 2017-yilda ro'yxatga olingan va Massachusets shtatining Uoterdaun shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Daniel J. Hicklin Ph.D. | Founder, CEO, President, Secretary & Director |
| Mr. Michael Urban | VP of Finance, Corporate Controller, Principal Financial Officer & Principal Accounting Officer |
| Mr. Steven H. Bloom R.Ph. | Chief Business Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | howl-20260507.htm |
| 2026-03-27 | 8-K | howl-20260327.htm |
| 2026-02-24 | 8-K | d808115d8k.htm |
| 2026-02-13 | 8-K | d110809d8k.htm |
| 2026-02-06 | 8-K | d101154d8k.htm |
| 2025-12-18 | 8-K | d21464d8k.htm |
| 2025-11-04 | 8-K | howl-20251104.htm |
| 2025-11-04 | 10-Q | howl-20250930.htm |
| 2025-10-06 | 8-K | d12663d8k.htm |
| 2025-08-14 | 8-K | howl-20250814.htm |